Share Price and Basic Stock Data
Last Updated: January 29, 2026, 11:12 am
| PEG Ratio | 0.34 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sicagen India Ltd operates in the Trading and Distributors industry, with a market capitalization of ₹205 Cr and a current share price of ₹51.8. The company reported sales of ₹895 Cr for the financial year ending March 2023, reflecting a growth from ₹836 Cr in the previous year. However, sales are projected to decline to ₹795 Cr in FY 2024 before slightly recovering to ₹892 Cr in FY 2025. The quarterly sales figures show variability, with the highest recorded at ₹258.19 Cr in December 2022 and a low of ₹166.43 Cr in June 2023. Despite these fluctuations, the company maintained a steady operational presence, with an average quarterly sales figure of approximately ₹200 Cr in the latest quarters. The company’s operational profit margin (OPM) stood at 4.00%, indicating a modest efficiency in converting sales into profit, which is below industry benchmarks, suggesting room for improvement in operational efficiency.
Profitability and Efficiency Metrics
Sicagen India Ltd reported a net profit of ₹17 Cr for FY 2023, a significant increase from a loss of ₹1 Cr in FY 2022. This improvement in profitability is complemented by a return on equity (ROE) of 3.41% and a return on capital employed (ROCE) of 5.57%. The interest coverage ratio (ICR) stood at 3.95x, indicating that the company is capable of meeting its interest obligations comfortably. However, the operating profit margin (OPM) reflects challenges, as it has fluctuated between 1.37% and 5.07% over the past year, with the most recent OPM reported at 4.00%. This variability suggests that while the company has made strides in profitability, maintaining consistent margins remains a challenge. Additionally, the net profit margin stood at 1.91%, which is relatively low compared to sector averages, indicating potential inefficiencies in cost management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Sicagen India Ltd reflects a solid foundation, with total assets recorded at ₹722 Cr and total liabilities at ₹722 Cr, indicating a balanced financial structure. The company has reported reserves of ₹478 Cr, which provides a buffer for future growth and operational expenditures. However, borrowings have increased to ₹164 Cr, up from ₹121 Cr in the previous fiscal year, indicating a rising leverage that could pose risks if not managed effectively. The current ratio stood at 2.29, suggesting good short-term liquidity, while the quick ratio of 1.70 indicates that the company can cover its short-term liabilities without relying on inventory. The price-to-book value (P/BV) ratio is at 0.50x, suggesting that the stock is undervalued relative to its book value, which could attract value investors looking for opportunities in the market.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sicagen India Ltd shows a strong promoter holding of 61.13%, which reflects confidence from the management in the company’s long-term prospects. Foreign institutional investors (FIIs) hold 2.42%, while domestic institutional investors (DIIs) account for 0.58%, indicating limited institutional interest. Public shareholding stands at 35.88%, with a total of 23,326 shareholders. The gradual increase in promoter stake from 45.66% in December 2022 to the current level suggests a positive outlook from insiders, potentially enhancing investor confidence. However, the declining trend in the number of shareholders from 25,689 in December 2022 to 23,326 in September 2025 raises concerns about retail investor interest, which could impact liquidity and overall market sentiment towards the stock.
Outlook, Risks, and Final Insight
Looking ahead, Sicagen India Ltd faces both opportunities and challenges. The expected recovery in sales to ₹892 Cr in FY 2025, alongside a projected increase in net profit to ₹17 Cr, indicates a potential turnaround in performance. However, the risks associated with rising borrowings and fluctuating profit margins could hinder growth. Additionally, external factors such as market volatility and changing regulatory environments may impact operations. Strengths include a solid promoter backing and healthy liquidity ratios, which can support strategic initiatives and operational stability. Conversely, the low institutional interest and concerns regarding margin consistency represent significant risks. Investors should monitor the company’s ability to maintain profitability and manage debt effectively, as these factors will be crucial in determining the long-term viability and growth potential of Sicagen India Ltd.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Millennium Online Solutions (India) Ltd | 7.60 Cr. | 1.52 | 2.88/1.52 | 0.81 | 0.00 % | 4.61 % | 5.54 % | 1.00 | |
| Minal Industries Ltd | 55.2 Cr. | 2.88 | 5.59/2.60 | 36.8 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 11.3 Cr. | 12.8 | 17.8/11.7 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 5.23 Cr. | 57.5 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 147 Cr. | 47.1 | 54.5/10.2 | 164 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| Industry Average | 8,591.97 Cr | 151.60 | 85.24 | 120.60 | 0.43% | 15.22% | 8.81% | 7.62 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 245.82 | 258.19 | 227.42 | 166.43 | 180.08 | 227.70 | 221.23 | 232.26 | 197.71 | 210.26 | 251.65 | 204.54 | 226.76 |
| Expenses | 242.46 | 251.32 | 216.05 | 157.99 | 174.97 | 222.48 | 212.85 | 222.99 | 189.44 | 203.04 | 240.91 | 194.80 | 217.70 |
| Operating Profit | 3.36 | 6.87 | 11.37 | 8.44 | 5.11 | 5.22 | 8.38 | 9.27 | 8.27 | 7.22 | 10.74 | 9.74 | 9.06 |
| OPM % | 1.37% | 2.66% | 5.00% | 5.07% | 2.84% | 2.29% | 3.79% | 3.99% | 4.18% | 3.43% | 4.27% | 4.76% | 4.00% |
| Other Income | 2.95 | 1.87 | 7.55 | 1.32 | 1.49 | 2.85 | 1.44 | 2.03 | 2.72 | 3.18 | 2.27 | 1.92 | 1.75 |
| Interest | 2.05 | 2.28 | 2.64 | 2.59 | 2.47 | 2.65 | 2.94 | 2.62 | 2.83 | 2.50 | 3.07 | 3.04 | 2.71 |
| Depreciation | 2.78 | 2.13 | 3.55 | 2.12 | 2.12 | 2.19 | 3.33 | 2.29 | 2.31 | 2.39 | 3.51 | 2.39 | 2.37 |
| Profit before tax | 1.48 | 4.33 | 12.73 | 5.05 | 2.01 | 3.23 | 3.55 | 6.39 | 5.85 | 5.51 | 6.43 | 6.23 | 5.73 |
| Tax % | 37.16% | 20.32% | 12.25% | 24.75% | 35.32% | 28.17% | 12.68% | 24.88% | 29.23% | 23.77% | 38.26% | 27.13% | 27.75% |
| Net Profit | 0.93 | 3.45 | 11.17 | 3.80 | 1.30 | 2.32 | 3.10 | 4.80 | 4.14 | 4.20 | 3.97 | 4.54 | 4.14 |
| EPS in Rs | 0.24 | 0.87 | 2.82 | 0.96 | 0.33 | 0.59 | 0.78 | 1.21 | 1.05 | 1.06 | 1.00 | 1.15 | 1.05 |
Last Updated: December 29, 2025, 3:58 am
Below is a detailed analysis of the quarterly data for Sicagen India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 226.76 Cr.. The value appears strong and on an upward trend. It has increased from 204.54 Cr. (Jun 2025) to 226.76 Cr., marking an increase of 22.22 Cr..
- For Expenses, as of Sep 2025, the value is 217.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 194.80 Cr. (Jun 2025) to 217.70 Cr., marking an increase of 22.90 Cr..
- For Operating Profit, as of Sep 2025, the value is 9.06 Cr.. The value appears to be declining and may need further review. It has decreased from 9.74 Cr. (Jun 2025) to 9.06 Cr., marking a decrease of 0.68 Cr..
- For OPM %, as of Sep 2025, the value is 4.00%. The value appears to be declining and may need further review. It has decreased from 4.76% (Jun 2025) to 4.00%, marking a decrease of 0.76%.
- For Other Income, as of Sep 2025, the value is 1.75 Cr.. The value appears to be declining and may need further review. It has decreased from 1.92 Cr. (Jun 2025) to 1.75 Cr., marking a decrease of 0.17 Cr..
- For Interest, as of Sep 2025, the value is 2.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.04 Cr. (Jun 2025) to 2.71 Cr., marking a decrease of 0.33 Cr..
- For Depreciation, as of Sep 2025, the value is 2.37 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.39 Cr. (Jun 2025) to 2.37 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 5.73 Cr.. The value appears to be declining and may need further review. It has decreased from 6.23 Cr. (Jun 2025) to 5.73 Cr., marking a decrease of 0.50 Cr..
- For Tax %, as of Sep 2025, the value is 27.75%. The value appears to be increasing, which may not be favorable. It has increased from 27.13% (Jun 2025) to 27.75%, marking an increase of 0.62%.
- For Net Profit, as of Sep 2025, the value is 4.14 Cr.. The value appears to be declining and may need further review. It has decreased from 4.54 Cr. (Jun 2025) to 4.14 Cr., marking a decrease of 0.40 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.05. The value appears to be declining and may need further review. It has decreased from 1.15 (Jun 2025) to 1.05, marking a decrease of 0.10.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:38 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 620 | 645 | 601 | 711 | 738 | 820 | 699 | 542 | 836 | 895 | 795 | 892 | 893 |
| Expenses | 631 | 644 | 608 | 707 | 737 | 817 | 688 | 533 | 814 | 869 | 768 | 856 | 856 |
| Operating Profit | -11 | 1 | -7 | 3 | 1 | 3 | 11 | 9 | 22 | 27 | 28 | 36 | 37 |
| OPM % | -2% | 0% | -1% | 0% | 0% | 0% | 2% | 2% | 3% | 3% | 3% | 4% | 4% |
| Other Income | 41 | 18 | 18 | 15 | 15 | 15 | 11 | 8 | -0 | 15 | 7 | 9 | 9 |
| Interest | 7 | 6 | 6 | 7 | 9 | 9 | 9 | 5 | 6 | 9 | 11 | 11 | 11 |
| Depreciation | 6 | 5 | 5 | 4 | 5 | 6 | 10 | 10 | 11 | 11 | 10 | 10 | 11 |
| Profit before tax | 17 | 8 | -1 | 8 | 2 | 3 | 3 | 1 | 5 | 22 | 14 | 24 | 24 |
| Tax % | 1% | 13% | -300% | 3% | 30% | 95% | 89% | 322% | 112% | 18% | 24% | 29% | |
| Net Profit | 17 | 7 | 1 | 7 | 1 | 0 | 0 | -3 | -1 | 18 | 11 | 17 | 17 |
| EPS in Rs | 4.27 | 1.67 | 0.27 | 1.89 | 0.29 | 0.03 | 0.09 | -0.81 | -0.15 | 4.50 | 2.66 | 4.32 | 4.26 |
| Dividend Payout % | 19% | 36% | 224% | 32% | 206% | 1,218% | 550% | -74% | -162% | 13% | 23% | 23% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -58.82% | -85.71% | 600.00% | -85.71% | -100.00% | 66.67% | 1900.00% | -38.89% | 54.55% |
| Change in YoY Net Profit Growth (%) | 0.00% | -26.89% | 685.71% | -685.71% | -14.29% | 166.67% | 1833.33% | -1938.89% | 93.43% |
Sicagen India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 5% |
| 3 Years: | 2% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 113% |
| 3 Years: | 136% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 45% |
| 3 Years: | 27% |
| 1 Year: | -30% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:31 pm
Balance Sheet
Last Updated: January 7, 2026, 4:24 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 |
| Reserves | 441 | 439 | 443 | 345 | 353 | 343 | 336 | 355 | 383 | 400 | 420 | 444 | 478 |
| Borrowings | 73 | 48 | 60 | 89 | 97 | 119 | 96 | 79 | 95 | 121 | 121 | 148 | 164 |
| Other Liabilities | 119 | 84 | 76 | 105 | 114 | 184 | 133 | 72 | 140 | 68 | 143 | 90 | 148 |
| Total Liabilities | 673 | 610 | 619 | 578 | 604 | 685 | 605 | 546 | 656 | 629 | 723 | 722 | 830 |
| Fixed Assets | 64 | 59 | 57 | 183 | 203 | 151 | 168 | 168 | 141 | 141 | 140 | 137 | 140 |
| CWIP | 0 | 1 | 2 | 12 | 0 | 0 | 1 | 0 | -0 | 0 | 1 | -0 | 1 |
| Investments | 100 | 100 | 100 | 54 | 34 | 26 | 20 | 37 | 70 | 69 | 73 | 79 | 93 |
| Other Assets | 509 | 451 | 460 | 329 | 367 | 507 | 417 | 340 | 445 | 418 | 510 | 505 | 596 |
| Total Assets | 673 | 610 | 619 | 578 | 604 | 685 | 605 | 546 | 656 | 629 | 723 | 722 | 830 |
Below is a detailed analysis of the balance sheet data for Sicagen India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 40.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 40.00 Cr..
- For Reserves, as of Sep 2025, the value is 478.00 Cr.. The value appears strong and on an upward trend. It has increased from 444.00 Cr. (Mar 2025) to 478.00 Cr., marking an increase of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 164.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 148.00 Cr. (Mar 2025) to 164.00 Cr., marking an increase of 16.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 148.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.00 Cr. (Mar 2025) to 148.00 Cr., marking an increase of 58.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 830.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 722.00 Cr. (Mar 2025) to 830.00 Cr., marking an increase of 108.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 140.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Mar 2025) to 140.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2025) to 93.00 Cr., marking an increase of 14.00 Cr..
- For Other Assets, as of Sep 2025, the value is 596.00 Cr.. The value appears strong and on an upward trend. It has increased from 505.00 Cr. (Mar 2025) to 596.00 Cr., marking an increase of 91.00 Cr..
- For Total Assets, as of Sep 2025, the value is 830.00 Cr.. The value appears strong and on an upward trend. It has increased from 722.00 Cr. (Mar 2025) to 830.00 Cr., marking an increase of 108.00 Cr..
Notably, the Reserves (478.00 Cr.) exceed the Borrowings (164.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -84.00 | -47.00 | -67.00 | -86.00 | -96.00 | -116.00 | -85.00 | -70.00 | -73.00 | -94.00 | -93.00 | -112.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 61 | 71 | 75 | 91 | 119 | 108 | 115 | 107 | 76 | 114 | 94 |
| Inventory Days | 70 | 56 | 59 | 70 | 68 | 58 | 78 | 80 | 50 | 65 | 67 | 60 |
| Days Payable | 35 | 19 | 19 | 32 | 42 | 75 | 60 | 40 | 60 | 24 | 47 | 20 |
| Cash Conversion Cycle | 110 | 98 | 110 | 113 | 117 | 102 | 126 | 155 | 97 | 117 | 134 | 134 |
| Working Capital Days | 67 | 69 | 78 | 67 | 73 | 61 | 99 | 114 | 84 | 85 | 97 | 88 |
| ROCE % | 2% | 2% | 1% | 3% | 2% | 3% | 3% | 2% | 4% | 4% | 4% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.81 |
| Diluted EPS (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.81 |
| Cash EPS (Rs.) | 6.98 | 5.12 | 7.17 | 2.61 | 1.70 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 122.31 | 116.19 | 111.08 | 106.73 | 99.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 122.31 | 116.19 | 111.08 | 106.73 | 99.75 |
| Revenue From Operations / Share (Rs.) | 225.39 | 201.02 | 226.26 | 211.31 | 136.88 |
| PBDIT / Share (Rs.) | 11.01 | 8.66 | 8.77 | 7.72 | 4.25 |
| PBIT / Share (Rs.) | 8.35 | 6.19 | 6.11 | 4.96 | 1.74 |
| PBT / Share (Rs.) | 6.11 | 3.50 | 5.47 | 1.27 | 0.36 |
| Net Profit / Share (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.80 |
| NP After MI And SOA / Share (Rs.) | 4.32 | 2.65 | 4.50 | -0.15 | -0.80 |
| PBDIT Margin (%) | 4.88 | 4.30 | 3.87 | 3.65 | 3.10 |
| PBIT Margin (%) | 3.70 | 3.07 | 2.69 | 2.34 | 1.27 |
| PBT Margin (%) | 2.71 | 1.73 | 2.41 | 0.59 | 0.26 |
| Net Profit Margin (%) | 1.91 | 1.31 | 1.99 | -0.07 | -0.59 |
| NP After MI And SOA Margin (%) | 1.91 | 1.31 | 1.99 | -0.07 | -0.59 |
| Return on Networth / Equity (%) | 3.53 | 2.28 | 4.05 | -0.14 | -0.81 |
| Return on Capital Employeed (%) | 6.58 | 5.12 | 5.29 | 4.47 | 1.60 |
| Return On Assets (%) | 2.37 | 1.50 | 2.83 | -0.09 | -0.56 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.27 | 0.22 | 0.24 | 0.18 | 0.16 |
| Asset Turnover Ratio (%) | 1.26 | 1.20 | 1.39 | 0.85 | 0.66 |
| Current Ratio (X) | 2.29 | 2.17 | 2.38 | 2.01 | 2.57 |
| Quick Ratio (X) | 1.70 | 1.58 | 1.55 | 1.54 | 1.76 |
| Inventory Turnover Ratio (X) | 6.85 | 2.28 | 3.78 | 0.70 | 0.48 |
| Dividend Payout Ratio (NP) (%) | 13.85 | 22.59 | 5.55 | -388.52 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 8.58 | 11.69 | 3.49 | 22.96 | 0.00 |
| Earning Retention Ratio (%) | 86.15 | 77.41 | 94.45 | 488.52 | 0.00 |
| Cash Earning Retention Ratio (%) | 91.42 | 88.31 | 96.51 | 77.04 | 0.00 |
| Interest Coverage Ratio (X) | 3.95 | 3.22 | 3.91 | 5.18 | 3.08 |
| Interest Coverage Ratio (Post Tax) (X) | 2.36 | 1.98 | 2.29 | 2.37 | 0.41 |
| Enterprise Value (Cr.) | 307.23 | 291.78 | 198.21 | 139.51 | 85.90 |
| EV / Net Operating Revenue (X) | 0.34 | 0.36 | 0.22 | 0.16 | 0.15 |
| EV / EBITDA (X) | 7.05 | 8.52 | 5.71 | 4.57 | 5.10 |
| MarketCap / Net Operating Revenue (X) | 0.27 | 0.29 | 0.13 | 0.10 | 0.10 |
| Retention Ratios (%) | 86.14 | 77.40 | 94.44 | 488.52 | 0.00 |
| Price / BV (X) | 0.50 | 0.50 | 0.27 | 0.20 | 0.14 |
| Price / Net Operating Revenue (X) | 0.27 | 0.29 | 0.13 | 0.10 | 0.10 |
| EarningsYield | 0.07 | 0.04 | 0.14 | -0.01 | -0.05 |
After reviewing the key financial ratios for Sicagen India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.32. This value is below the healthy minimum of 5. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.32. This value is below the healthy minimum of 5. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.98. This value is within the healthy range. It has increased from 5.12 (Mar 24) to 6.98, marking an increase of 1.86.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.31. It has increased from 116.19 (Mar 24) to 122.31, marking an increase of 6.12.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 122.31. It has increased from 116.19 (Mar 24) to 122.31, marking an increase of 6.12.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 225.39. It has increased from 201.02 (Mar 24) to 225.39, marking an increase of 24.37.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 11.01. This value is within the healthy range. It has increased from 8.66 (Mar 24) to 11.01, marking an increase of 2.35.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.35. This value is within the healthy range. It has increased from 6.19 (Mar 24) to 8.35, marking an increase of 2.16.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.11. This value is within the healthy range. It has increased from 3.50 (Mar 24) to 6.11, marking an increase of 2.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.32. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.32. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 4.32, marking an increase of 1.67.
- For PBDIT Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 10. It has increased from 4.30 (Mar 24) to 4.88, marking an increase of 0.58.
- For PBIT Margin (%), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 10. It has increased from 3.07 (Mar 24) to 3.70, marking an increase of 0.63.
- For PBT Margin (%), as of Mar 25, the value is 2.71. This value is below the healthy minimum of 10. It has increased from 1.73 (Mar 24) to 2.71, marking an increase of 0.98.
- For Net Profit Margin (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 5. It has increased from 1.31 (Mar 24) to 1.91, marking an increase of 0.60.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 8. It has increased from 1.31 (Mar 24) to 1.91, marking an increase of 0.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.53. This value is below the healthy minimum of 15. It has increased from 2.28 (Mar 24) to 3.53, marking an increase of 1.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.58. This value is below the healthy minimum of 10. It has increased from 5.12 (Mar 24) to 6.58, marking an increase of 1.46.
- For Return On Assets (%), as of Mar 25, the value is 2.37. This value is below the healthy minimum of 5. It has increased from 1.50 (Mar 24) to 2.37, marking an increase of 0.87.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.27, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.26. It has increased from 1.20 (Mar 24) to 1.26, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 2.17 (Mar 24) to 2.29, marking an increase of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 1.70, marking an increase of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.85. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 6.85, marking an increase of 4.57.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 13.85. This value is below the healthy minimum of 20. It has decreased from 22.59 (Mar 24) to 13.85, marking a decrease of 8.74.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 20. It has decreased from 11.69 (Mar 24) to 8.58, marking a decrease of 3.11.
- For Earning Retention Ratio (%), as of Mar 25, the value is 86.15. This value exceeds the healthy maximum of 70. It has increased from 77.41 (Mar 24) to 86.15, marking an increase of 8.74.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.42. This value exceeds the healthy maximum of 70. It has increased from 88.31 (Mar 24) to 91.42, marking an increase of 3.11.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.95. This value is within the healthy range. It has increased from 3.22 (Mar 24) to 3.95, marking an increase of 0.73.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 3. It has increased from 1.98 (Mar 24) to 2.36, marking an increase of 0.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 307.23. It has increased from 291.78 (Mar 24) to 307.23, marking an increase of 15.45.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.36 (Mar 24) to 0.34, marking a decrease of 0.02.
- For EV / EBITDA (X), as of Mar 25, the value is 7.05. This value is within the healthy range. It has decreased from 8.52 (Mar 24) to 7.05, marking a decrease of 1.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.29 (Mar 24) to 0.27, marking a decrease of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 86.14. This value exceeds the healthy maximum of 70. It has increased from 77.40 (Mar 24) to 86.14, marking an increase of 8.74.
- For Price / BV (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.50.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.29 (Mar 24) to 0.27, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.07, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sicagen India Ltd:
- Net Profit Margin: 1.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.58% (Industry Average ROCE: 15.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.53% (Industry Average ROE: 8.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.36
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.7
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.6 (Industry average Stock P/E: 85.24)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 4th Floor, SPIC House, No.88, Mount Road, Chennai (Madras) Tamil Nadu 600032 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashwin C Muthiah | Chairman |
| Mr. Nandakumar Varma | Whole Time Director |
| Mr. R Chandrasekar | Director |
| Mr. Batchu Sai Purshotham | Independent Director |
| Ms. Govindarajan Dattatreyan Sharma | Independent Director |
| Ms. Rita Chandrasekar | Independent Director |
FAQ
What is the intrinsic value of Sicagen India Ltd?
Sicagen India Ltd's intrinsic value (as of 29 January 2026) is ₹69.42 which is 32.48% higher the current market price of ₹52.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹207 Cr. market cap, FY2025-2026 high/low of ₹83.5/49.5, reserves of ₹478 Cr, and liabilities of ₹830 Cr.
What is the Market Cap of Sicagen India Ltd?
The Market Cap of Sicagen India Ltd is 207 Cr..
What is the current Stock Price of Sicagen India Ltd as on 29 January 2026?
The current stock price of Sicagen India Ltd as on 29 January 2026 is ₹52.4.
What is the High / Low of Sicagen India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sicagen India Ltd stocks is ₹83.5/49.5.
What is the Stock P/E of Sicagen India Ltd?
The Stock P/E of Sicagen India Ltd is 13.6.
What is the Book Value of Sicagen India Ltd?
The Book Value of Sicagen India Ltd is 131.
What is the Dividend Yield of Sicagen India Ltd?
The Dividend Yield of Sicagen India Ltd is 1.91 %.
What is the ROCE of Sicagen India Ltd?
The ROCE of Sicagen India Ltd is 5.57 %.
What is the ROE of Sicagen India Ltd?
The ROE of Sicagen India Ltd is 3.41 %.
What is the Face Value of Sicagen India Ltd?
The Face Value of Sicagen India Ltd is 10.0.